Updates in Antiplatelet & Antithrombotic Treatments for ASCVD: Should You Consider Ticagrelor and Prasugrel in Patients With ACS? When to Use Triple Therapy and How Helpful Is It in Reducing Bleeding?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Updates in Antiplatelet & Antithrombotic Treatments for ASCVD: Should You Consider Ticagrelor and Prasugrel in Patients With ACS? When to Use Triple Therapy and How Helpful Is It in Reducing Bleeding?

By 4th Annual Cardiovascular Conference: Advances in Cardiovascular Disease - from Prevention to Intervention FEATURING Sripal Bangalore

0 views

April 22, 2021

Comments 0

A Journey through Five Phase 3 Clinical Trials for a T2D Incretin Me…

Feat. B. Hirsch

A Journey through Five Phase 3 Clinical Trials for a T2D Incretin Me…

Feat. B. Hirsch

Ambulatory Blood Pressure Monitoring

26:11

13th Orange County Symposium for Cardiovascular Disease Prevention

Update on Calcium Screening and CTA: Role in Prevention

Feat. M. Budoff

42:28

Scripps Health

CT Coronary Calcium Scoring, Hard Plaque and Soft Plaque Visualizati…

Feat. M. Budoff

59:01

The North American Thrombosis Forum (NATF)

Recent Cholesterol Guidelines and Integration into Clinical Practice

Feat. J. Plutzky, L. Braun, J. Ross

18:43

Canadian Collaborative Research Network

Lp(a): When to Measure it and What to Do About it

Feat. M. O'Donoghue

19:16

The Texas Heart Institute

Role of Coronary Calcification and Risk Stratification

Feat. E. Hernandez

14:39

Lankenau

Management of AF patients with ACS

Feat. P. Kowey, D. Ice

08:44

AHA 2022 Conference Coverage

AHA 2022: Cardiovascular Benefit of Lowering LDL Cholesterol Below 4…

Feat. N. Marston

14:50

AHA 2022 Conference Coverage

AHA 2022: Long-Term Efficacy and Safety of Inclisiran in Patients Wi…

Feat. K. Ray

24:02

Complex Coronary Cases

Updated Lipid Guidelines and Therapy

Feat. I. Fergus

19:24

National Lipid Association

Do Triglycerides Cause Heart Disease?

Feat. I. Goldberg

34:20

Cedars Sinai

Cardiology’s Biggest Controversy: The Lumen or the Wall - the Curiou…

Feat. J. Forrester

15:40

ACC 2022 Conference Coverage

ACC 2022: Triple Therapy - When to Use and How Long

Feat. D. Kumbhani

21:34

Canadian Collaborative Research Network

Should Colchicine Become Standard Therapy for CAD?

Feat. P. Ridker

45:45

Houston Methodist DeBakey Heart and Vascular Center

Directions of Cardiology in the Next Decade: 2022-2032

Feat. E. Braunwald

31:02

Scripps Health

How Do I Reverse Coronary Plaque?

Feat. C. J. Suhar

28:05

Michael Makover

The Deadly Paradox: Current Practice, Driven by Guidelines, Is Not A…

19:58

Complex Coronary Cases

New Frontiers in Cardiovascular Health: Chronological vs Biological …

Feat. V. Fuster

31:27

Scripps Health

Evaluate the Horrible Cholesterol Lp(a): Prevalence, Impact and Nove…

Feat. N. Lepor

19:48

ACC 2022 Conference Coverage

ACC 2022: Updates on Lowering LDL-C in Secondary Prevention - "…

Feat. R. Giugliano

Login

Login

Join VuMedi

Updates in Antiplatelet & Antithrombotic Treatments for ASCVD: Should You Consider Ticagrelor and Prasugrel in Patients With ACS? When to Use Triple Therapy and How Helpful Is It in Reducing Bleeding?

Recommended